Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esomeprazole for Prevention of Preeclampsia (ESOPOP)
NCT03717740Phase 3Unknown
- Sponsor
- Aswan University Hospital
- Start
- Dec 2018
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in preeclampsia comparing Esomeprazole with Placebo (2 arms). Primary endpoint: Number of Participants With early onset Preeclampsia at 6 months. Status: unknown.
02
Drugs
esomeprazole
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT03717740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03717740.